Tag: Rob Plesnarski
Cancer drug firm Adlai Nortye raises USD97.5m in Nasdaq IPO
O’Melveny, Han Kun Law Offices, Maples Group, Latham & Watkins and Zhong Lun Law Firm advised on cancer drug developer Adlai Nortye’s Nasdaq debut
O’Melveny, Han Kun Law Offices, Maples Group, Latham & Watkins and Zhong Lun Law Firm advised on cancer drug developer Adlai Nortye’s Nasdaq debut
For Marco Chung, group head of legal at CITIC Securities International, the choice for arbitration seat in China-related disputes is clear